ornithine has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; He, F; Li, X; Ma, L; Mei, C; Song, M; Wang, C; Yang, Y; Zhou, J | 1 |
| Ahmadi, A; Beisswenger, PJ; Blackburn, NJR; Brownlee, M; Cimenci, CE; Gonzalez-Gomez, M; McNeill, B; Milne, RW; Ostojic, A; Suuronen, EJ; Vulesevic, B; Zhong, Z | 1 |
2 other study(ies) available for ornithine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
The role of the complement factor B-arginase-polyamine molecular axis in uremia-induced cardiac remodeling in mice.
Topics: Animals; Arginase; Arginine; Complement Factor B; Macrophages; Mice; Nitric Oxide; Ornithine; Polyamines; Signal Transduction; Uremia; Ventricular Remodeling | 2020 |
Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Topics: Animals; Apoptosis; Cells, Cultured; Collagen Type I; Disease Models, Animal; Genetic Predisposition to Disease; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Lactoylglutathione Lyase; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Ornithine; Phenotype; Pyruvaldehyde; Signal Transduction; Stem Cells; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |